EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Achieving Hierarchical Selective Ablation and Remodeling “Cold” Tumors via a Dual‐Organelle‐Targeted AIE Nanoplatform: Synergizing Ferroptosis, ICD, and cGAS–STING Activation

Wenkai Zhang, Xueke Yan, Xiepeng Deng, Chen Cui, Dalu Xie, Ben Zhong Tang, Huifang Su

Aggregate · 2026-09 · 7 (9)

DOI: 10.1002/agt2.70426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aggregate, online erschienen am 30.08.2026. Verfasst von Wenkai Zhang und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has created new opportunities for treating triple‐negative breast cancer (TNBC), but its benefit is often limited by an immunosuppressive tumor microenvironment. Here, we report BMFL, a folate receptor‐targeted liposomal nanoplatform that co‐delivers a near‐infrared aggregation‐induced emission luminogens (AIEgens), BITT, and the STING agonist MSA‐2 for dual‐organelle‐directed photoimmunotherapy. BMFL enables fluorescence discrimination of lipid droplets and lysosomes and, under phototherapy, couples lipid droplet peroxidation‐driven ferroptosis with lysosome‐associated immunogenic cell death (ICD). Ferroptosis‐associated mitochondrial stress promotes endogenous mtDNA leakage, which cooperates with the delivered exogenous MSA‐2 to drive upstream activation of the STING pathway; meanwhile, immunostimulatory signals released during ICD further synergize with the STING‐mediated inflammatory microenvironment to achieve downstream amplification of adaptive antitumor immunity. In a bilateral tumor model, BMFL‐mediated therapy not only eradicates primary tumors but also elicits systemic antitumor immunity and suppresses distal tumor growth. In this study, BMFL functions as a dual‐organelle‐targeting nanoplatform that enhances therapeutic efficacy by coupling ferroptosis with ICD through the cGAS–STING pathway, offering a potential strategy for treating poorly immunogenic breast tumors.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, W., Yan, X., Deng, X., Cui, C., Xie, D., Tang, B. Z., & Su, H. (2026). Achieving Hierarchical Selective Ablation and Remodeling “Cold” Tumors via a Dual‐Organelle‐Targeted AIE Nanoplatform: Synergizing Ferroptosis, ICD, and cGAS–STING Activation. Aggregate, 7(9). https://doi.org/10.1002/agt2.70426

Vancouver

Zhang W, Yan X, Deng X, Cui C, Xie D, Tang BZ, et al. Achieving Hierarchical Selective Ablation and Remodeling “Cold” Tumors via a Dual‐Organelle‐Targeted AIE Nanoplatform: Synergizing Ferroptosis, ICD, and cGAS–STING Activation. Aggregate. 2026;7(9). doi:10.1002/agt2.70426

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenkai and Yan, Xueke and Deng, Xiepeng and Cui, Chen and Xie, Dalu and Tang, Ben Zhong and Su, Huifang},
  title = {Achieving Hierarchical Selective Ablation and Remodeling “Cold” Tumors via a Dual‐Organelle‐Targeted AIE Nanoplatform: Synergizing Ferroptosis, ICD, and cGAS–STING Activation},
  journal = {Aggregate},
  year = {2026},
  volume = {7},
  number = {9},
  doi = {10.1002/agt2.70426}
}
Kostenlos starten →